Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden administration proposed Tuesday morning.

Key Takeaways The Biden administration proposed a new policy Tuesday that would allow Medicare and Medicaid to cover medications prescribed to treat obesity, such as Ozempic and Wegovy, in 2026.Under current rules,